Application of 18‑fluorodeoxyglucose as an indicator of symptom severity in a rat model of tic disorder following treatment with traditional Chinese medicine

  • Authors:
    • Pengcheng Zhu
    • Min Wu
    • Bitao Ma
    • Shuxia Wang
  • View Affiliations

  • Published online on: November 19, 2020     https://doi.org/10.3892/etm.2020.9483
  • Article Number: 51
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Quantitative evaluation of tic disorders (TDs) is challenging as there are few objective indicators that can be used for the assessment of treatment outcomes. 18F‑Fluorodeoxyglucose (FDG) is a radioactive tracer that is able to cross the blood‑brain barrier and can be detected by positron emission tomography/CT (PET/CT). In the present study, it was hypothesized that FDG PET/CT scan can be applied to reflect the severity of tic symptoms in a rat TD model, where signals detected in the brain striatum can be used to evaluate the efficacy of tic treatment with traditional Chinese medicine (TCM). A rat model of TD was established by treatment with iminodipropionitrile. Rats were divided into the following four groups (n=10 each): i) Control; ii) TCM; iii) haloperidol; and iv) model only. Observations of stereotypic behavior in rats were subsequently scored and micro‑PET/CT was used to evaluate the rate of FDG uptake. Stereotypy scores were found to be significantly higher (P<0.05) in the TD rat model (P<0.05) compared with those in control rats. Both stereotypy scores (P<0.05) and standardized FDG uptake values (SUV; P<0.05) were revealed to be significantly reduced in the TD model rats after treatment with TCM or haloperidol. SUV correlated positively with stereotypy score (R=0.926; P<0.05) and the SUV scores were found to be significantly different among control group, TCM group, haloperidol group and model only group (P<0.05). These data suggest that the application of FDG in the striatum can be used to evaluate the effectiveness of TCM treatment for TDs.
View Figures
View References

Related Articles

Journal Cover

January-2021
Volume 21 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhu P, Wu M, Ma B and Wang S: Application of 18‑fluorodeoxyglucose as an indicator of symptom severity in a rat model of tic disorder following treatment with traditional Chinese medicine. Exp Ther Med 21: 51, 2021.
APA
Zhu, P., Wu, M., Ma, B., & Wang, S. (2021). Application of 18‑fluorodeoxyglucose as an indicator of symptom severity in a rat model of tic disorder following treatment with traditional Chinese medicine. Experimental and Therapeutic Medicine, 21, 51. https://doi.org/10.3892/etm.2020.9483
MLA
Zhu, P., Wu, M., Ma, B., Wang, S."Application of 18‑fluorodeoxyglucose as an indicator of symptom severity in a rat model of tic disorder following treatment with traditional Chinese medicine". Experimental and Therapeutic Medicine 21.1 (2021): 51.
Chicago
Zhu, P., Wu, M., Ma, B., Wang, S."Application of 18‑fluorodeoxyglucose as an indicator of symptom severity in a rat model of tic disorder following treatment with traditional Chinese medicine". Experimental and Therapeutic Medicine 21, no. 1 (2021): 51. https://doi.org/10.3892/etm.2020.9483